Showing results (1691-1700 of 2,743) with videos related to
Sort By:
Pageof 275
Expert Review of Neurotherapeutics|June 15, 2007
Oxcarbazepine in the treatment of bipolar and schizoaffective disordersEkaterine Popova, Caroline Leighton, Antoni Bernabarre, et al.Expert Review of Neurotherapeutics|June 15, 2007
Genetics of Parkinson's disease and parkinsonismMichael R Douglas, Alistair J Lewthwaite, David J NichollExpert Review of Neurotherapeutics|June 15, 2007
Intervening in the neuropsychiatric features of Parkinson's diseaseDaniel Weintraub, Matthew B SternExpert Review of Neurotherapeutics|July 6, 2007
Recent developments in psychosocial treatments for schizophrenic patientsGlenn D SheanExpert Review of Neurotherapeutics|September 23, 2009
Angiotensin AT1-receptor blockers and cerebrovascular protection: do they actually have a cutting edge over angiotensin-converting enzyme inhibitors?Roxana Oprisiu-Fournier, Sébastien Faure, Hakim Mazouz, et al.Expert Review of Neurotherapeutics|September 23, 2009
Multiple sclerosis lesions: insights from imaging techniquesValentina Tomassini, Jacqueline PalaceExpert Review of Neurotherapeutics|September 23, 2009
Post-traumatic headacheMark Obermann, Dagny Holle, Zaza KatsaravaExpert Review of Neurotherapeutics|September 23, 2009
Homocysteine, folate and vitamin B12 in neuropsychiatric diseases: review and treatment recommendationsOlaf Stanger, Brian Fowler, Klaus Piertzik, et al.Expert Review of Neurotherapeutics|September 23, 2009
Prevention of dementia by antihypertensive drugs: how AT1-receptor-blockers and dihydropyridines better prevent dementia in hypertensive patients than thiazides and ACE-inhibitorsAlbert Fournier, Roxana Oprisiu-Fournier, Jean-Marie Serot, et al.Expert Review of Neurotherapeutics|August 14, 2009
Targeting eNOS and beyond: emerging heterogeneity of the role of endothelial Rho proteins in stroke protectionNaoki Sawada, James K LiaoPageof 275